[Form 4] PubMatic, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Steven Pantelick, Chief Financial Officer of PubMatic, Inc. (PUBM), reported a sale of Class A common stock under a pre-established Rule 10b5-1 trading plan. The filing discloses that on 08/27/2025 he sold 3,676 shares at a weighted-average price of $8.4363, with prices in the range $8.31 to $8.52. After the reported sale, the filing shows the reporting person beneficially owned 27,026 shares. The Form 4 was signed by an attorney-in-fact on 08/29/2025. All sales were effected pursuant to the 10b5-1 plan adopted May 9, 2024.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating the sale was pre-planned
- Weighted-average price and price range disclosed, providing transparent pricing details
Negative
- Insider sold 3,676 shares, which represents insider liquidity though materiality relative to total holdings is not provided
- No additional context on rationale beyond the 10b5-1 plan, so the sale provides limited insight into company fundamentals
Insights
TL;DR: Insider sale under a pre-set 10b5-1 plan; transaction is transparent and routine, with limited immediate informational content for valuation.
The Form 4 reports a disposition of 3,676 Class A shares by PubMatic's CFO on 08/27/2025 at a weighted-average price of $8.4363. The filing explicitly states the sale was executed under a 10b5-1 trading plan adopted May 9, 2024, which reduces the likelihood the sale reflects contemporaneous insider views about business prospects. The remaining beneficial ownership is 27,026 shares. From an analyst perspective, the report documents insider liquidity but does not provide new operational or financial data to alter revenue or earnings forecasts.
TL;DR: Governance process appears followed; 10b5-1 plan use and attorney-in-fact signature support procedural compliance.
The filing shows appropriate procedural disclosures: the sale is identified as executed pursuant to a Rule 10b5-1 plan and the price range and weighted-average price are disclosed. The signature by an attorney-in-fact on 08/29/2025 is noted. These elements indicate compliance with Section 16 reporting requirements and transparency around the insider transaction. The filing does not disclose any amendments or atypical arrangements that would raise governance concerns.